Inceptor Bio and Avectas Collaborate to Improve Manufacturing of CAR-T’s for Solid TumorsCell therapy biotechnology company Inceptor Bio and engineering technology leader Avectas have announced that they will collaborate to…Jan 10, 2023Jan 10, 2023
EMA Accepts Application for Breakthrough Treatment of Genetic Form of ALSBiogen, a leading global biotech company, has announced that the European Medicines Agency (EMA) has accepted its marketing authorization…Jan 10, 2023Jan 10, 2023
Charles River Expands Cell Therapy CDMO CapacityCharles River, an international pharmaceutical developer, has announced the expansion of its cell therapy contract development and…Jan 10, 2023Jan 10, 2023
Merit Complete UK’s First CAR-T Cell Manufacturing Facility for Autolus TherapeuticsOffsite engineering and construction company, Merit, has completed the first stage of its £66m car-T cell manufacturing facility, which is…Jan 10, 2023Jan 10, 2023
Arcellx and Kite Announce Collaboration to Develop CAR-T for Multiple MyelomaGlobal pharmaceutical company Kite, a Gilead company, and clinical-stage biotechnology company Arcellx have announced a strategic…Jan 10, 2023Jan 10, 2023
